comparemela.com

Latest Breaking News On - Haffkine biopharmaceutical corporation - Page 6 : comparemela.com

Maharashtra allows Haffkine Bio-Pharma to manufacture Covid vaccines

Maharashtra allows Haffkine Bio-Pharma to manufacture Covid vaccines April 28, 2021 × The Maharashtra Government at its Cabinet meeting on Wednesday permitted Haffkine Bio-Pharmaceutical Corporation Ltd, to start a project for manufacturing COVID vaccines. The project would be implemented at a cost of Rs 154 crore, a press statement issued by the Chief Minister office said.  Haffkine Biopharmaceutical Corporation Ltd makes drugs and vaccines for serious infectious diseases such as polio. It is a fully owned Maharashtra Government company registered under the Companies Act, in 1975. It is an offshoot of the Haffkine Institute, which is one of the oldest human biological research laboratories in the country.

Maharashtra to provide free Covid vaccines to all in the 18-44 age group

Maharashtra to provide free Covid vaccines to all in the 18-44 age group April 28, 2021 × Till date, more than 1.5 crore people in the age group of 45 and above have been vaccinated The decision to provide free Covid vaccines to all the people in the age group of 18 to 44 in Maharashtra was taken at the state cabinet meeting on Wednesday afternoon, a media statement issued by the Chief Minister Office said. At the meeting, Chief Minister Uddhav Thackeray made the announcement and said that the State Health Department is planning for the vaccination programme and the citizens will be informed about it in advance. Vaccines from Serum Institute and Bharat Biotech are currently available, and in consultation with the companies is under way so that more and more vaccines will be made available in the State.

IIL confident of Covaxin rollout by August - The Hindu BusinessLine

IIL confident of Covaxin rollout by August April 20, 2021 Company looks to start rolling out vaccine batches from July-August 2021 With its expertise in rabies vaccine production using the vero cell platform, public sector vaccine-maker Indian Immunologicals Ltd (IIL), an arm of the National Dairy Development Board (NDDB), is confident of starting Covaxin production by July/August as this vaccine uses the same technology, a top company official said. The Centre is looking to accelerate production of the indigenous vaccine and has roped in IIL, Bharat Immunologicals & Biologicals Corporation (BIBCOL) and Haffkine Biopharmaceutical Corporation to collectively provide 10-15 million doses a month by August-September.

The Political Fix: Why do we know so little about the calculations behind India s vaccine rollout?

The Political Fix: Why do we know so little about the calculations behind India s vaccine rollout?
scroll.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scroll.in Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.